Aims: To estimate the effect on drug misuse treatment completion of a pilot scheme to pay service providers according to rates of recovery. Design: A controlled, quasi-experimental (difference-in-differences) observational study using multi-level random effects logistic regression. Setting: Drug misuse treatment providers in all 149 commissioning areas in England in the financial years 2011–12 and 2012–13. Participants: Service users treated in England in 2011–12 and 2012–13. Intervention and comparators: Linkage of provider payments to performance indicators in eight pilot commissioning areas in England compared with all 141 non-pilot commissioning areas in England. Measurements: Recovery was measured by successful completion of treat...
Our understanding of patient pathways through specialist Alcohol and Other Drug treatment and broade...
Background and Aims: Our understanding of patient pathways through specialist Alcohol and Other Drug...
BACKGROUND AND AIMS: Our understanding of patient pathways through specialist Alcohol and Other Drug...
Aims To estimate the effect on drug misuse treatment completion of a pilot scheme to pay service pro...
AIM: To compare drug recovery outcomes in commissioning areas included in a 'payment by results' sch...
AIMS: To estimate how a scheme to pay substance misuse treatment service providers according to trea...
AIMS: To estimate how a scheme to pay substance misuse treatment service providers according to trea...
Aims: To estimate how a scheme to pay substance misuse treatment service providers according to trea...
Objective To examine whether the introduction of payment by results (a fixed tariff case mix based p...
Following an expert seminar to explore the issues around applying payment by results to drug recover...
Aims: Some economic costs and consequences of drug misuse and treatment were investigated among clie...
INTRODUCTION: The positive impact of substance use treatment is well-evidenced but there has been su...
This paper reviews what has been learned from the following major national drug treatment outcome st...
<p>Background: Research on the prevalence and significance of previous treatment is limited, but ind...
A unique analysis of drug treatment data shows more people are overcoming dependency and services ar...
Our understanding of patient pathways through specialist Alcohol and Other Drug treatment and broade...
Background and Aims: Our understanding of patient pathways through specialist Alcohol and Other Drug...
BACKGROUND AND AIMS: Our understanding of patient pathways through specialist Alcohol and Other Drug...
Aims To estimate the effect on drug misuse treatment completion of a pilot scheme to pay service pro...
AIM: To compare drug recovery outcomes in commissioning areas included in a 'payment by results' sch...
AIMS: To estimate how a scheme to pay substance misuse treatment service providers according to trea...
AIMS: To estimate how a scheme to pay substance misuse treatment service providers according to trea...
Aims: To estimate how a scheme to pay substance misuse treatment service providers according to trea...
Objective To examine whether the introduction of payment by results (a fixed tariff case mix based p...
Following an expert seminar to explore the issues around applying payment by results to drug recover...
Aims: Some economic costs and consequences of drug misuse and treatment were investigated among clie...
INTRODUCTION: The positive impact of substance use treatment is well-evidenced but there has been su...
This paper reviews what has been learned from the following major national drug treatment outcome st...
<p>Background: Research on the prevalence and significance of previous treatment is limited, but ind...
A unique analysis of drug treatment data shows more people are overcoming dependency and services ar...
Our understanding of patient pathways through specialist Alcohol and Other Drug treatment and broade...
Background and Aims: Our understanding of patient pathways through specialist Alcohol and Other Drug...
BACKGROUND AND AIMS: Our understanding of patient pathways through specialist Alcohol and Other Drug...